Metraipolis › archive › dc_bb236b351848

CRISPR-Cas9 Therapeutics in Early Clinical Development: Delivery and Molecular Diagnostics — Europe PMC PMID:41972732

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41972732
DOI
10.3390/cells15070644
License (as archived)
solo-consultazione
Archived
2026-11-03T12:08:24.653Z
SHA-256 of the archived text
cf860527a323505e2df3cd7e9460592b5ce417cf1e50aeb800de150b9c468d28
Stable URL of this page
https://metraipolis.com/documento/dc_bb236b351848

How to cite

CRISPR-Cas9 Therapeutics in Early Clinical Development: Delivery and Molecular Diagnostics — Europe PMC PMID:41972732 — Europe PMC (en), https://europepmc.org/article/MED/41972732 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bb236b351848 (Metraipolis archive dc_bb236b351848, sha256 cf860527a323505e2df3cd7e9460592b5ce417cf1e50aeb800de150b9c468d28)
BibTeX
@misc{dcbb236b351848,
  title = {CRISPR-Cas9 Therapeutics in Early Clinical Development: Delivery and Molecular Diagnostics — Europe PMC PMID:41972732},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41972732},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bb236b351848; sha256 cf860527a323505e2df3cd7e9460592b5ce417cf1e50aeb800de150b9c468d28},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41972732. Agents can read the archived copy with the MCP tool read_document.